Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
RhoVac
Tag: RhoVac
Chosa eyes publication of phase IIb-results
1 March, 2023
RhoVac becomes Chosa Oncology after acquisition
20 January, 2023
Chosa Oncology gets Chinese patent green light
23 December, 2022
The 5 best life science stocks so far in 2022
3 October, 2022
RhoVac gives update on phase IIb results and presents action plan
4 July, 2022
Top 5 life science stocks – first half of 2022
1 July, 2022
New findings support the use of RhoVac’s cancer vaccine in several...
20 May, 2022
Database lock in RhoVac’s phase IIb study
11 May, 2022
Cancer vaccines – a new frontier in immuno-oncology
7 April, 2022
Scientific publication supports RhoVac’s cancer treatment method
1 March, 2022
1
2
3
Page 1 of 3